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Purpose: Transcription factors of the nuclear factor-kappa beta (NF–κB) family have been demonstrated to play an
important role in the regulation of gene expression in the chronic neurodegenerative disorders. The aims of the current
study were to investigate the alteration of NF-κB activity during retinal degeneration in rd mice and further explore its
role in photoreceptor apoptosis.
Methods: Activation of NF-κB and its nuclear translocation in the retina of rd mice at postnatal days (P) 8, 10, 12, 14,
16, 18, and 28 were studied by immunohistochemical analysis using NF-κB P65 antibody. The amount of NF-κB P65
protein and NF-κB DNA-binding activity in the whole retina were assessed by western blot analysis and gel shift analysis,
respectively. Expression of NF-κB in microglial cells labeled with CD11b was determined by double labeling.
Results: NF-κB P65 nuclear translocation and its DNA binding activity started to increase in the rd retina at P10 and
reached a peak at P12. Expressions of P65 remained at high levels from P12 to P18. Double labeling of P65 with CD11
at P14 showed colocalization of P65 in the microglial cells in the outer nuclear layer.
Conclusions: NF-κB was activated in the retinal degeneration of rd mice. NF-κB modulation may play a role in the retinal
degeneration through microglial activation.
Recent studies have shown that there is a strong link
between  inflammation  and  chronic  neurodegenerative
diseases, such as Alzheimer disease, Parkinson disease, and
Creutzfeldt–Jakob disease [1]. The common feature of these
diseases is neuroinflammation, defined as the presence of
activated microglia and inflammatory mediators. Microglia,
resident macrophages of the central nervous system (CNS),
are central to the inflammatory response. These cells actively
monitor their environment and can become over-activated in
response to diverse stimuli to produce cytotoxic factors, such
as superoxide [2], nitric oxide [3], and tumor necrosis factor
alpha (TNF-α) [4,5].
Retinitis pigmentosa (RP) is a group of inherited retinal
degenerations  characterized  by  progressive  loss  of
photoreceptor  cells.  More  than  158  genes  causing  this
inherited retinal disease have been identified in about two-
thirds  of  the  cases  (Retnet).  However,  the  molecular
mechanisms  by  which  these  gene  mutations  lead  to
photoreceptor apoptosis have not been clearly elucidated. In
a recent study, we showed several inflammatory events and
factors were involved in the retinal degenerative process of
rd mice [6]. In this widely used retinitis pigmentosa animal
model, a mutation in the gene encoding the β subunit of retinal
cyclic guanosine monophosphate (cGMP) phosphodiesterase
results in elevation of cGMP levels in rod photoreceptors,
leading to massive cell death by apoptosis [7,8]. In that study,
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the  activation  of  microglia,  as  well  as  expression  of
chemokines  and  microglia-derived  neurotoxic  cytokines
(TNF-α),  coincided  with  or  preceded  the  occurrence  of
photoreceptor apoptosis, suggesting inflammatory response
may play an important role in the retinal degeneration in rd
mice.
The  proinflammatory  responses  of  immune  cells,
including microglia, involve the signal transduction molecule
transcription factor nuclear factor-kappa beta (NF-κB) [9].
Activation of NF-κB contributes to microglia activation and
production of proinflammatory molecules [10] that can lead
to neurotoxicity in vivo [11]. NF-κB signaling begins with
phosphorylation and degradation of IκB, a key component of
the cytoplasmic NF-κB complex [12], and releases the p50
and p65 subunits that translocate to the nucleus and promote
transcription  of  proinflammatory  genes  [13].  In  many
neurodegenerative diseases, a significant increase of NF-κB
activity was detected in neurons and microglial cells in brains
of patients [14–17]. In this study, we examined the activity of
NF-κB during retinal degeneration of rd mice and defined its
role in the inflammatory process of this neurodegenerative
model.
METHODS
Animals: This study used 120 inbred C3H/HeJ rd and wild-
type C3H mice (Jackson Laboratories, Bar Harbor, ME) . All
animals were treated in accordance with the ARVO statement
for the use of Animals in Ophthalmic and Vision Research.
Euthanasia was performed by placing mice in a CO2 chamber
for 60 s, followed by cervical dislocation. The globes of the
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1075rd mice were collected on postnatal days (P) 8, P10, P12, P14,
P16, P18, and P28. Age-matched normal C3H mice were used
as controls. Mice were euthanized at the same time of the day
(1:00 PM).
Tissue preparation: After the mice were sacrificed, their eyes
were rapidly enucleated and fresh-frozen in optimal cutting
temperature compound (Tissue-Tek; Sakura Finetek, Tokyo,
Japan) in liquid nitrogen and stored at −80 °C until sectioning.
Figure 1. Immunochemical localization of NF-κBP65 in rd retinas and controls. A: In control retinas, weak immunoreactivity was present in
the cytoplasm of cells in the ganglion cell layer (GCL), inner plexiform layer (IPL), and outer plexiform layer (OPL). The inserted picture
showed magnified positive cells in the OPL. B: In the rd retina at P12, P65 immunoreactivity peaked, and prominent nuclear labeling of the
cells was evident in the OPL. P65 immunoreactivity remained in the cytoplasm in the cells of GCL. The inserted picture in the upper right
angle showed a magnified cell with nuclear labeling in the OPL. The inserted picture in the lower right angle showed a magnified cell with
cytoplasm labeling in the GCL C: In the rd retina at P14, migration of the cells with intense nuclear labeling was seen toward the outer nuclear
layer (ONL). The inserted picture showed a magnified cell with nuclear labeling in the ONL. D: In the rd retina at P16, P65 immunoreactivity
was still prominent, but the cells with nuclear labeling were hardly seen. E-G: Double labeling of NF-κB P65 and CD 11b in the rd retina at
P14 showed co-localization of NF-κB in microglial cells in the outer retina. E: Microglial cells were shown in green color; F: NF-κB P65
immunoreactivity was shown in red color. G: Expression of NF-κB P65 in the microglial cells was shown in orange color. The arrow shows
positive labeling. In the figure, the inner nuclear layer is abbreviated INL. Scale bar equals 100 μm.
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1076The tissue blocks were cut vertically with a cryostat at 8 μm
through the optic nerve head and ora serrata.
Immunohistochemistry  of  NF-κB  and  fluorescent  double-
labeling  of  NF-κB  and  microglia:  NF-κB  P65
immunolabeling was performed with a kit (MOM; Vector
laboratories,  Burlingame,  CA)  according  to  the
manufacturer’s instructions. In brief, frozen sections were
fixed in acetone, quenched in 0.3% H2O2 in methanol, and
incubated  in  a  mouse  IgG  blocking  solution  for  1  h.  A
monoclonal antibody that recognizes the active form of NF-
κB (NF-κB P65; Santa Cruz Biotechnology; Santa Cruz, CA)
was  applied  at  a  1:100  dilution,  and  the  sections  were
incubated at 4 °C overnight. NF-κB P65 immunoreactivity
was detected using a biotinylated secondary antibody, and
3,3′-diaminobenzidine was used as the chromogen. Negative
controls were performed by replacing the primary antibody
with PBS.
For double labeling, the tissue sections were incubated
with two primary antibodies from different species (NF-κB
P65 antibody from mouse and CD 11b antibody from rat) at
4 °C overnight. After the sections were washed in PBS for 15
min, they were incubated with secondary antibodies from their
corresponding  species,  conjugated  with  either  1:100
fluorescein isothiocyanate (FITC; Jackson ImmunoResearch
Laboratory, West Grove; PA) or 1:200 tetramethylrhodamine
isothiocyanate (TRITC) for 45 min at room temperature. The
sections  were  observed  with  a  confocal  laser  scanning
microscope (TCS-NT; Leica, Wetzlar, Germany) with 488 nm
filter for FITC green and 568 nm filter for TRITC. Images
were  captured  and  postprocessed  by  digital  photography
(DXL-5500;  Sony,  Tokyo,  Japan)  and  confocal  software
(Leica).
Western  blot  analysis:  Retinal  tissues  were  homogenized
using a tissue grinder (Thomas 3431E15; Phoenix Equipment,
Inc.; Rochester, NY) in 500 μl of cold suspension buffer
(20 mM HEPES-KOH (pH7.5), with 250 mM sucrose, 10 mM
KCL, 1 mM EDTA, 1 mM EGTA, and 1 mM DTT) containing
proteinase  inhibitor  cocktail  (Roche  Diagnostics,
Indianapolis,  IN).  The  homogenates  were  centrifuged  at
750x g at 4 °C. Each 5 μg sample was separated on a 12%
SDS–PAGE  gel,  and  western  blot  analysis  was  then
performed  as  previously  described  [18].  Briefly,  the
electrophoresed proteins were electrophoretically transferred
to nitrocellulose membrane for immunodetection. Western
blots were blocked with buffer containing 5% non-fat milk
and incubated with primary polyclonal antibody NF-κB P65
(sc-372; Santa Cruz Biotechnology, Santa Cruz, CA). Primary
antibody  binding  was  identified  with  secondary  antibody
conjugated to horseradish peroxidase (1:2000; Santa Cruz
Biotechnology)  followed  by  chemiluminescent  detection
(ECL  kit,  Amersham  Corp.,  Arlington  Heights,  IL).  The
polyclonal  antibody  (sc-372;  Santa  Cruz  Biotechnology),
which reacts with an epitope consisting of 20 amino acids at
the  COOH-terminus  of  NF-κB  P65,  was  used  for
immunodetection. Protein concentration of all samples were
measured using a bicinchoninic acid (BCA) protein assay kit
(Pierce,  Rockford,  IL)  before  western  blot  analysis,  and
equivalent amount of protein were used for the assay. In each
blot, GAPDH was used as an internal control for the loading
of protein level. Fluorescence bands were digitally captured
for analysis of intensity (Quantity One Image Software; Bio-
Rad Laboratories, Santa Cruz, CA).
Electrophoretic  mobility  shift  assay:  The  preparation  of
retinal  nuclear  extracts  and  determination  of  the  NF-κB
DNA–binding activity were performed with a nuclear and
cytoplasmic  reagent  kit  (NE-PER;  Pierce)  and  an
electrophoretic  mobility  shift  assay  (EMSA)
chemiluminescence  kit  (LightShift;  Pierce),  respectively,
according to the manufacturer’s protocols. A double-stranded
oligonucleotide  containing  an  NF-κB  DNA–binding
consensus sequence, 5′-AGT TGA GGG GAC TTT CCC
AGG C-3′ (Santa Cruz Biotechnology), and a mutant double-
stranded oligonucleotide, 5′-AGT TGA GGC GAC TTT CCC
AGG C-3′, were used to study NF-κB DNA–binding activity,
as previously described [19]. Briefly, 2 µg of nuclear extracts
from the whole retina was preincubated in a reaction mixture
for  20  min,  and  biotin  end-labeled,  double-stranded
Figure 2. Western blot analysis of NF-κB P65 protein levels in
control and rd retinas for each age group. A: Little expression of NF-
κB P65 (bands at 65 kDa) was found in the control retinas at different
age groups. B: NF-κB P65 protein was detected in the samples from
rd retinas. GAPDH (35 kDa) was used as a loading control. C:
Intensitometry  of  immunoreactive  bands  in  rd  retinas.  Note  the
protein levels of NF-κB P65 in rd retinas were significantly increased
at P10 and reached a peak at P12. It kept a high level up to P18 and
was markedly reduced by P28 (*p<0.05, compared with the control
retina, n=6).
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1077oligonucleotide containing the κB consensus sequence was
added. Next, 5 µl of loading buffer was added to each sample.
A 20 µl aliquot of the samples was electrophoresed through a
6%  nondenaturing  polyacrylamide  gel.  The  hybridization
signal was quantified by intensitometry using Quantity One
Image Software (Bio-Rad Laboratories)
Statistical  analysis:  The  data  were  presented  as  mean
±standard  deviation.  Statistical  significance  was  assessed
with a one-way ANOVA followed by Tukey’s HSD Multiple
Comparisons  test.  A  p<0.05  was  considered  statistically
significant.
RESULTS
Nuclear translocation of NF-κB in the microglial cells in the
rd retina: In the control retina (P14, Figure 1A), NF-κB P65
positive  cells  were  scattered  in  the  inner  retinal  layers,
including the ganglion cell layer (GCL), inner plexiform layer
(IPL),  and  outer  plexiform  layer  (OPL).  P65
immunoreactivity mainly appeared in the cytoplasm of the
cells. In the rd retina, P65 immunoreactivity was increased
and peaked at P12. At this time point, prominent nuclear
translocation in the OPL was noted (Figure 1B). At P14, cells
with P65 nuclear labeling were found in the outer nuclear layer
(ONL; Figure 1C). At P16, P65 immunoreactivity in the retina
was still prominent, but the positive cells in the outer retina
were reduced (Figure 1D). Double labeling of NF-κB p65 and
CD11b  at  P14  showed  P65  immunoreactivity  was
predominantly in the microglial cells infiltrating the ONL
(Figure 1E-G).
Upregulation  of  NF-κB  in  the  rd  retinas:  Western  blot
analysis was performed to assess the protein level of NF-
κBP65 in retinas during retinal degeneration of rd mice. In the
control  retinas  of  different  age  groups,  there  was  little
expression  of  NF-κB  P65  and  no  significant  difference
between each age group (Figure 2A). In the rd retinas, the
amount  of  NF-κB  P65  was  notably  increased  at  P10  and
reached a peak at P12. The expression was kept a high level
up to P18. The expression of P65 was markedly reduced at
P28. (Figure 2B,C)
Increased NF-κB DNA–binding activity in rd retinas: We
performed EMSAs to determine levels of nuclear NF-κBP65
DNA–binding activity in rd retinas. In the EMSA blot, there
were two prominent bands. The intensity of the upper band
(NF-κB P65) was increased in the rd retina at P10, reached its
maximum at P12, and decreased at P16. The specificity of the
upper band was determined by the application of excess cold
(unlabeled) and mutant κB double oligonucleotides in the
assay. (Figure 3A,B)
DISCUSSION
In this study, we demonstrated increased expression of NF-
κB protein and NF-κB DNA-binding activity in the retina
during  photoreceptor  degeneration  of  rd  mice.  Nuclear
translocation of NF-κB was noted in the microglial cells in the
OPL and ONL. In a previous study [6], we showed cytokine
TNF-α, a representative target and inducer gene for NF-κB
activation,  was  also  primarily  produced  in  the  activated
microglial cells in the outer retina of rd mice. Taking our
previous study and the present one together, we propose that
activation of NF-κB may be associated with photoreceptor
cell  death  through  regulation  of  gene  expression  of
proinflammatory and neurotoxic molecules (e.g., TNF-α) in
microglial cells in the rd retina.
As in CNS neurodegenerative diseases, alteration of NF-
κB  expression  has  been  reported  in  several  retinal
degenerations both in vitro and in vivo. Krishnamoorthy and
colleagues [20] showed cultured 661W mouse photoreceptor
cells constitutively expressed NF-κB, and light exposure of
these cells resulted in lowering of NF-κB levels in both the
nuclear and cytosolic fractions in a time-dependent manner.
In contrast, Wu et al. [21]. reported in vivo expression of NF-
κB in photoreceptor cells was increased at 3 h and its nuclear
translocation  was  evident  at  12  h  after  continuous  light
Figure 3. Electrophoretic mobility shift assay showing increased NF-
κB  DNA–binding  activity  in  developing  rd  retinas.  A:
Representative gel shift analysis of NF-κB DNA and nuclear protein
combination  in  control  and  rd  retinas.  Lane  1:  NF-κB  was
constitutively active in control retinas. Lanes 2–5: NF-κB DNA–
binding activity in the nuclei of retinal cells in rd mice at P10, P12,
P14, and P16, respectively. Lanes 6 and 7: NF-κB DNA–binding
activity by competition electrophoretic mobility shift assay (EMSA),
with  mutant  and  a  hundredfold  M  excess  of  cold  NF-κB
oligonucleotides, respectively. B: Quantification of NF-κB DNA–
binding activity in control and rd retinas shown in (A). Note NF-κB
DNA-binding activity in rd retinas were significantly increased at
P10, reached a peak at P12, and decreased at P16 (*p<0.05, compared
with the control retina, n=6).
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1078exposure for 3 h. Activation of NF-κB was also observed in
neuronal cells in the inner nuclear layer and ganglion cell layer
24 h following retinal ischemia and reperfusion injury [22].
In the latter study, P65 labeling was partially colocalized with
apoptotic cells in the inner nuclear cell layer. Consistent with
the aforedescribed two animal models of retinal degeneration,
our study revealed marked NF-κB activation in the retina of
rd mice, a typical model for inherited retinal dystrophy.
In contrast to previous studies on retinal degenerations,
activation of NF-κB in the rd retina in the present study was
primarily in microglial cells, rather than in neuronal cells,
including photoreceptor cells. This observation might imply
a distinct function of NF-κB activation in retinal degeneration
in this animal model. Pro-apoptotic and anti-apoptotic roles
of NF-κB in neuronal and glial cells including microglia and
astrocytes have been identified and proposed in several CNS
neurodegenerative diseases [23–25]. These studies reported
that activation of NF-κB in neurons played a neuroprotective
role  in  the  neurodegenerative  conditions  [26–28].  In  this
scenario, NF-κB influences the neurodegenerative process by
directly  promoting  cell  survival  gene  expression,  such  as
Bcl-2, Mn-SOD, and inhibitor of apoptosis protein [29,30], or
reducing cell death gene expression, such as Bxl-x and Bax in
neurons [31]. In contrast, the role of NF-κB activation in glial
cells,  especially  microglia  are  usually  neurotoxic  as
production  of  many  proinflammatory  cytokines  and
proapoptotic substances including TNF-α, IL-1β, iNOS, and
the cell adhesion molecule (ICAM-1) were regulated by NF-
κB  in  glial  cells  [4,32].  In  retinal  degenerations,  NF-κB
showed a neuroprotective role in photoreceptor apoptosis in
vitro as transfection of these cells with a dominant negative
mutant IkB greatly enhanced kinetics of down modulation of
NF- B, resulting in a faster photo-oxidative stress-induced
apoptosis [20]. The function of NF-κB in the retina in vivo
appeared  unclear,  although  P65  immunolabeling  positive
cells were TUNEL negative in light-induced photoreceptor
degeneration [21]. The present study suggests a neurotoxic
role of NF-κB in photoreceptor apoptosis by not only showing
its persistent high expression levels in rd retinas spanning
from P12 to P18 when the photoreceptor cell loss took place,
but also revealing its activation in microglial cells and co-
occurrence of increased TNF-α production in microglial cells
in a typical period (from P12 to P14) of retinal degenerations
of rd mice [6].
NF-κB is an important signaling molecule in microglial
activation.  Activation  of  NF-κB  indirectly  influences
neurodegenerative process by regulating gene expression in
microglial cells, including pro-inflammatory cytokines TNF-
α [33]. TNF-α may serve as both target and inducer gene of
NF-κB  activation.  Like  other  neurodegenerative  diseases,
TNF-α and other NF-κB-dependent gene products may be
responsible  for  persistent  NF-κB  activation  and  sustained
chronic  retinal  inflammation  in  rd  mice,  even  as  the
photoreceptor cells disappeared in the advanced stage.
In summary, the present study showed marked activation
of  NF-κB  in  microglial  cells  in  the  retinal  degenerative
process of rd mice. Alteration of NF-κB activity may promote
photoreceptor  apoptosis  via  initiation  and  perpetuation  of
chronic inflammation in the rd retina, making it an extremely
attractive target for therapeutic intervention.
ACKNOWLEDGMENTS
This work was supported by grants from Micheal Panitch
Research  Fund  (M.O.M.T.),  the  Mr.  and  Mrs.  John  Linn
Research Fund (H.Z.) and a grant from the National Institute
on Drug Abuse, National Institutes of Health (NIH R01-DA
DA15020; S.L.).
REFERENCES
1. Minghetti  L.  Role  of  inflammation  in  neurodegenerative
diseases.  Curr  Opin  Neurol  2005;  18:315-21.  [PMID:
15891419]Click here to read
2. Colton CA, Gilbert DL. Production of superoxide anions by a
CNS  macrophage,  the  microglia.  FEBS  Lett  1987;
223:284-8. [PMID: 2822487]
3. Liu X, Samouilov A, Lancaster JR, Zweier JL. Nitric oxide
uptake by erythrocytes is primarily limited by extracellular
diffusion  not  membrane  resistance.  J  Biol  Chem  2002;
277:26194-9. [PMID: 12006567]
4. Lee  SC,  Liu  W,  Dickson  DW,  Brosnan  CF,  Berman  JW.
Cytokine production by human fetal microglia and astrocytes.
Differential induction by lipopolysaccharide and IL-1 beta. J
Immunol 1993; 150:2659-67. [PMID: 8454848]
5. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production
of tumor necrosis factor-alpha by microglia and astrocytes in
culture. Brain Res 1989; 491:394-7. [PMID: 2765895]
6. Zeng HY, Zhu XA, Zhang C, Yang LP, Wu LM, Tso MO.
Identification of sequential events and factors associated with
microglial activation, migration, and cytotoxicity in retinal
degeneration in rd mice. Invest Ophthalmol Vis Sci 2005;
46:2992-9. [PMID: 16043876]
7. Farber  DB.  From  mice  to  men:  the  cyclic  GMP
phosphodiesterase gene in vision and disease.The Proctor
Lecture. Invest Ophthalmol Vis Sci 1995; 36:263-75. [PMID:
7843898]
8. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic
photoreceptor  cell  death  in  mouse  models  of  retinitis
pigmentosa.  Proc  Natl  Acad  Sci  USA  1994;  91:974-8.
[PMID: 8302876]
9. Madrid  LV,  Mayo  MW,  Reuther  JY,  Baldwin  AS  Jr.  Akt
stimulates  the  transactivation  potential  of  the  RelA/p65
Subunit of NF-kappa B through utilization of the Ikappa B
kinase and activation of the mitogen-activated protein kinase
p38. J Biol Chem 2001; 276:18934-40. [PMID: 11259436]
10. Pawate S, Shen Q, Fan F, Bhat NR. Redox regulation of glial
inflammatory  response  to  lipopolysaccharide  and
interferongamma. J Neurosci Res 2004; 77:540-51. [PMID:
15264224]
11. Zhang  W,  Stanimirovic  D.  Current  and  future  therapeutic
strategies to target inflammation in stroke. Curr Drug Targets
Inflamm Allergy 2002; 1:151-66. [PMID: 14561197]
12. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation
of NF-kappaB and IkappaB proteins: implications in cancer
Molecular Vision 2008; 14:1075-1080 <http://www.molvis.org/molvis/v14/a128> © 2008 Molecular Vision
1079and  inflammation.  Trends  Biochem  Sci  2005;  30:43-52.
[PMID: 15653325]
13. Chan  EL,  Murphy  JT.  Reactive  oxygen  species  mediate
endotoxin-induced  human  dermal  endothelial  NF-kappaB
activation. J Surg Res 2003; 111:120-6. [PMID: 12842456]
14. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg
M, Faucheux BA, Agid Y, Hirsch EC. Nuclear translocation
of NF-kB is increased in dopaminergic neurons of patients
with  Parkinson  disease.  Proc  Natl  Acad  Sci  USA  1997;
94:7531-6. [PMID: 9207126]
15. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt
C. Transcription factor NF-kB is activated in primary neurons
by  amyloid  b  peptides  and  in  neurons  surrounding  early
plaques from patients with Alzheimer disease. Proc Natl Acad
Sci USA 1997; 94:2642-7. [PMID: 9122249]
16. Terai  K,  Matsuo  A,  McGeer  PL.  Enhancement  of
immunoreactivity for NF-κB in the hippocampal formation
and cerebral cortex of Alzheimer’s disease. Brain Res 1996;
735:159-68. [PMID: 8905182]
17. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith
MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D.
Non-enzymatically  glycated  tau  in  Alzheimer’s  disease
induces neuronal oxidant stress resulting in cytokine gene
expression and release of amyloid b-peptide. Nat Med 1995;
1:693-9. [PMID: 7585153]
18. Wu TH, Ting TD, Okajima TI, Pepperberg DR, Ho YK, Ripps
H,  Naash  MI.  Opsin  localization  and  rhodopsin
photochemistry  in  a  transgenic  mouse  model  of  retinitis
pigmentosa.  Neuroscience  1998;  87:709-17.  [PMID:
9758235]
19. Shen  Y,  Rattan  V,  Sultana  C,  Kalra  VK.  Cigarette  smoke
condensate-induced  adhesion  molecule  expression  and
transendothelial migration of monocytes. Am J Physiol 1996;
270:H1624-33. [PMID: 8928867]
20. Krishnamoorthy RR, Crawford MJ, Chaturvedi MM, Jain SK,
Aggarwal BB, Al-Ubaidi MR, Agarwal N. Photo-oxidative
stress down-modulates the activity of nuclear factor-kappaB
via  involvement  of  caspase-1,  leading  to  apoptosis  of
photoreceptor cells. J Biol Chem 1999; 274:3734-43. [PMID:
9920926]
21. Wu T, Chen Y, Chiang SK, Tso MO. NF-kappaB activation in
light-induced retinal degeneration in a mouse model. Invest
Ophthalmol Vis Sci 2002; 43:2834-40. [PMID: 12202499]
22. Chen YG, Zhang C, Chiang SK, Wu T, Tso MO. Increased
nuclear  factor-kappa  B  p65  immunoreactivity  following
retinal ischemia and reperfusion injury in mice. J Neurosci
Res 2003; 72:125-31. [PMID: 12645086]
23. Baeuerle PA, Henkel T. Function and activation of NF-kappa
B  in  the  immune  system.  Annu  Rev  Immunol  1994;
12:141-79. [PMID: 8011280]
24. Kaltschmidt  C,  Kaltschmidt  B,  Neumann  H,  Wekerle  H,
Baeuerle PA. Constitutive NF-kappa B activity in neurons.
Mol Cell Biol 1994; 14:3981-92. [PMID: 8196637]
25. O'Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription
factor for glial and neuronal cell function. Trends Neurosci
1997; 20:252-8. [PMID: 9185306]
26. Goodman  Y,  Bruce  AJ,  Cheng  B,  Mattson  MP.  Estrogens
attenuate  and  corticosterone  exacerbates  excitotoxicity,
oxidative  injury,  and  amyloid  beta-peptide  toxicity  in
hippocampal  neurons.  J  Neurochem  1996;  66:1836-44.
[PMID: 8780008]
27. Mattson  MP,  Goodman  Y,  Luo  H,  Fu  W,  Furukawa  K.
Activation  of  NF-kappaB  protects  hippocampal  neurons
against  oxidative  stress-induced  apoptosis:  evidence  for
induction  of  manganese  superoxide  dismutase  and
suppression of peroxynitrite production and protein tyrosine
nitration. J Neurosci Res 1997; 49:681-97. [PMID: 9335256]
28. Ohlsson H, Edlund T. Sequence-specific interactions of nuclear
factors with the insulin gene enhancer. Cell 1986; 45:35-44.
[PMID: 3006925]
29. Tamatani  M,  Che  YH,  Matsuzaki  H,  Ogawa  S,  Okado  H,
Miyake S, Mizuno T, Tohyama M. Tumor necrosis factor
induces bcl-2 and bcl-x expression through NF-kB activation
in  primary  hippocampal  neurons.  J  Biol  Chem  1999;
274:8531-8. [PMID: 10085086]
30. Camandola  S,  Mattson  MP.  Pro-apoptotic  action  of  PAR-4
involves inhibition of NF-kappaB activity and suppression of
BCL-2 expression. J Neurosci Res 2000; 61:134-9. [PMID:
10878585]
31. Shou Y, Li N, Li L, Borowitz JL, Isom GE. NF-kB-mediated
up-regulation of Bcl-X(S) and Bax contributes to cytochrome
c release in cyanide-induced apoptosis. J Neurochem 2002;
81:842-52. [PMID: 12065643]
Molecular Vision 2008; 14:1075-1080 <http://www.molvis.org/molvis/v14/a128> © 2008 Molecular Vision
The print version of this article was created on 3 June 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1080